Strategic pillars strengthening our organisation
- Injectables
- Respiratory, Nasal, Semi-Solids and Liquids
- Solid Orals
- Unified criteria for selecting internal products and BD/M&A opportunities
- Disciplined investments that deliver strong returns and long-term growth
Expertise in three core technology platforms supported by global R&D operations
Leveraging global synergies, expertise and alignment
Q&A with Hafrun Fridriksdottir, EVP, Rx and R&D
Product selection sits at the heart of what we do. It's not a one-time exercise but a continuous, dynamic process where we constantly reprioritise our pipeline based on value creation and the competitive landscape.
Our R&D leaders
Discover what it's like to work at Hikma through our employee testimonials
Careers at Hikma